Silence Therapeutics Dividend
Dividend criteria checks 0/6
Silence Therapeutics does not have a record of paying a dividend.
Key information
n/a
Dividend yield
n/a
Payout ratio
Industry average yield | 2.9% |
Next dividend pay date | n/a |
Ex dividend date | n/a |
Dividend per share | n/a |
Earnings per share | -US$0.93 |
Dividend yield forecast in 3Y | n/a |
Recent dividend updates
No updates
Recent updates
Need To Know: Analysts Are Much More Bullish On Silence Therapeutics plc (NASDAQ:SLN) Revenues
Feb 07Subdued Growth No Barrier To Silence Therapeutics plc (NASDAQ:SLN) With Shares Advancing 65%
Nov 27Silence Therapeutics wins FDA’s fast track status for blood cancer therapy
Sep 08Silence Therapeutics prices 5.95M ADSs at $9.50/share
Aug 12New finance chief for Silence Therapeutics
Jan 06Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if SLN's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if SLN's dividend payments have been increasing.
Dividend Yield vs Market
Silence Therapeutics Dividend Yield vs Market |
---|
Segment | Dividend Yield |
---|---|
Company (SLN) | n/a |
Market Bottom 25% (US) | 1.5% |
Market Top 25% (US) | 4.7% |
Industry Average (Biotechs) | 2.9% |
Analyst forecast in 3 Years (SLN) | n/a |
Notable Dividend: Unable to evaluate SLN's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate SLN's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate SLN's payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as SLN has not reported any payouts.